Real‐world use and effectiveness of fostemsavir in a US clinical setting: Insights from Trio Health HIV Research Network
HIV Medicine · 2026-11 · 27 (11) · 1814-1822
DOI: 10.1111/hiv.70303 ↗Abstract
Abstract Objective To describe real‐world patterns of use, virologic and immunologic outcomes and treatment persistence among people with HIV (PWH) initiating fostemsavir (FTR) in a diverse US cohort. Design Retrospective cohort study of adults receiving FTR in clinical practice, stratified by baseline viral suppression status. Methods Adults with ≥1 FTR prescription between July 2020 and August 2023 were included and followed for 12 months. Individuals with trial participation were excluded. Outcomes included virologic suppression (
EUVIMED